Syros(SYRS) - 2023 Q1 - Earnings Call Transcript

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q1 2023 Earnings Conference Call May 10, 2023 8:30 AM ET Company Participants Karen Hunady - Director, Investor Relations and Corporate Communications Nancy Simonian - President, CEO & Director David Roth - Chief Medical Officer Jason Haas - CFO Conference Call Participants Philip Nadeau - TD Cowen Edward Tenthoff - Piper Sandler & Co. Jason Butler - JMP Securities Mark Breidenbach - Oppenheimer Operator Good morning, and welcome to Syros Pharmaceuticals' First Quar ...